Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.
Key Details
- 1More than 30 Mayo Clinic studies will be featured at the 2026 ASCO Annual Meeting.
- 2Highlighted topics include precision oncology, early cancer detection, and AI-driven analysis.
- 3A deep learning approach will be presented to quantify tumor microenvironment features in colon cancer trials.
- 4Research includes multicancer early detection testing and biomarker-driven treatments for various cancers.
- 5Specific sessions will address AI-enabled analysis of postoperative ctDNA status and clinical outcomes.
Why It Matters
Presentations on AI-powered tissue analysis and early detection signal accelerating integration of imaging AI into oncology care. Such advances can inform best practices for radiologists and collaborative cancer care teams.
Source
EurekAlert
Related News
•EurekAlert
AI-Enhanced Imaging Breaks Barriers in Complex Media for Biomedical Use
Researchers developed a physics-based machine learning imaging system that enhances visibility through complex media, holding promise for biomedical imaging.
•EurekAlert
AI Model Accelerates Accurate Dose Prediction for CyberKnife Radiotherapy
A physics- and spatially informed diffusion model accelerates Monte Carlo–level dose estimation for CyberKnife radiotherapy using planning CT and anatomical data.
•EurekAlert
New G-AUDIT Tool Detects Hidden Bias in Medical AI Training Data
Johns Hopkins and FDA researchers unveil G-AUDIT, a tool to identify hidden biases in medical AI datasets before model training.